Tag: ORA

Chunhui Xu, PhD, is an associate professor of pediatrics at Emory University School of Medicine specializing in cardiogenesis — the study of the development of the embryonic heart. Researchers in her lab turn human pluripotent (immature) stem cells, or hPSCs, into cardiac muscle cells. It’s an innovation that holds hope for disease modeling, drug screening, and regenerative medicine. March 2020 marked the end of a stellar project: Cardiac cells were shown to be cultivated more efficiently in the microgravity environment of space. The experiment, devised by Emory professor Chunhui Xu, PhD, in partnership with Kevin Maher, MD, began years ago Read More …

The singing of Bengalese finches led Samuel Sober, PhD, to a breakthrough technology for understanding how the brain controls movement and the processes of sensorimotor learning. “Songbirds are the best model system for understanding how the brain controls complex vocal behavior, and one of the best systems for understanding control of motor behavior in general,” says Sober, Emory associate professor of biology. This breakthrough comes after decades in the neuroscience field. After getting his bachelor’s in neuroscience and behavior, Sober pursued a doctorate in neuroscience at the University of California, San Francisco. His doctoral thesis researched human motor planning and Read More …

Stefan Sarafianos is the rare researcher whose expertise spans structural biology, biochemistry, and virology. He recently led the groundbreaking development of a SARS-CoV-2 subgenomic replicon system, including mutants, that can be used for high-throughput screening and characterization of SARS-CoV-2 replicase inhibitors at a lower biosafety level—considerable benefits for pursuing studies such as drug discovery and inhibitors assay. Many of us are familiar with the bedeviling question: “Do you want it faster, cheaper, and better? Pick one.” In the case of the replicon system Stefan Sarafianos has developed, researchers studying SARS-CoV-2 are able to benefit from all three and add one Read More …

For Emory Orthopedic Surgeon Eric Wagner, MD, research isn’t just a side pursuit. Despite maintaining a busy clinical practice, Wagner has managed to make research into what he calls a “second career.” Wagner and his partner, Michael Gottschalk, MD, currently have over 45 ongoing projects, with topics running the gambit from managing opioid addiction to helping tendons heal. Wagner has published over 185 articles in peer-reviewed journals, and his work has had a substantial impact in improving patient outcomes from orthopedic procedures. “We take some complex surgeries where patients don’t traditionally do as well and try to make them better Read More …

Erik Dreaden, PhD is an assistant professor in Emory’s department of pediatrics and department of biomedical engineering, a shared department between Emory and GA Tech. The Dreaden Lab has been working hard to create an exciting light-responsive immunotherapy technology. This unique technology works to target cancer cells using light. The goal of this developing technology is to improve current cancer therapies and immunotherapy. Dreaden’s interest in the field of cancer grew over time, as cancer has been a large part of his life. His father battled melanoma and colon cancer, so it has personally impacted his work and touched him. Read More …